Sarah Hughes

A new partnership combines clinical care with logistical support, aiming to solve the caregiving puzzle for employers and their increasingly stressed employees.

With zero debt and millions in cash, Atlas Energy is hunting for global oil and gas deals. But can it escape its unique regulatory 'Sandbox' status?

Flush with $60M in new funding, the AI code review leader taps Matthew Mulqueen to translate its technical dominance into global enterprise adoption.

USBC divests its sensor business to fully focus on tokenized deposits, a bold pivot into the risky but potentially revolutionary future of digital finance.

Performance PR agency Dreamday formalizes its influencer services, appointing Madeline Reid to drive measurable results in the booming creator economy.

With NASA's Artemis II circling the Moon, a coalition urges Congress to designate July 20 as a national day to honor Apollo's legacy and inspire explorers.

After an AI agent lost a fortune misreading a sarcastic post, Claw Wallet launches to build digital fortresses for the booming, but vulnerable, on-chain AI economy.

US AI firm Larx opens a UK subsidiary led by a military veteran, aiming to deliver 'decision intelligence' to allied defense and intelligence partners.

As dental RCM complexities grow, Zentist's key industry bootcamp moves to Nashville, focusing on AI-driven strategies for financial leaders.

With a massive profit jump, Vancity doubles down on community investment and branch expansion, challenging the Canadian banking industry's current trends.

LONGi unveils its all-in-one solar and storage system, aiming to simplify energy and challenge a fragmented market. But will customers buy into one vendor?

Facing labor shortages and rising costs, Midwest manufacturers are adopting vertical storage systems to recover up to 90% of their floor space.

A new survey reveals a startling gap: while over 70% of Hong Kongers see the need for home insurance, nearly 60% remain dangerously unprotected.

With Singaporeans losing over a billion to scams, a new insurance plan aims to protect your digital wallet from phishing, fraud, and e-commerce woes.

Biotech startup Infinimmune's 'human-first' AI platform lands a major deal with Merck, aiming to revolutionize how new antibody drugs are created.

A new partnership provides early access to an investigational drug for FAP, offering a potential non-surgical therapeutic option for the first time.

A new SANS report reveals the cyber workforce crisis has shifted. It's no longer about empty seats, but a critical skills gap driven by AI and regulation.

The neurotech pioneer reports strong sales for its spinal cord injury therapy, secures key FDA approvals, and plans for major US stock market entry.

A new AI test promises to tell patients their personal benefit from chemotherapy, aiming to end decades of one-size-fits-all treatment decisions.

Roche has received FDA clearance for two new high-speed diagnostic units designed to alleviate lab staff shortages and dramatically increase testing capacity.